231 related articles for article (PubMed ID: 12357336)
1. DHPLC analysis as a platform for molecular diagnosis of congenital disorders of glycosylation (CDG).
Schollen E; Martens K; Geuzens E; Matthijs G
Eur J Hum Genet; 2002 Oct; 10(10):643-8. PubMed ID: 12357336
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobic Man-1-P derivatives correct abnormal glycosylation in Type I congenital disorder of glycosylation fibroblasts.
Eklund EA; Merbouh N; Ichikawa M; Nishikawa A; Clima JM; Dorman JA; Norberg T; Freeze HH
Glycobiology; 2005 Nov; 15(11):1084-93. PubMed ID: 16079417
[TBL] [Abstract][Full Text] [Related]
3. Characterization of two unusual truncating PMM2 mutations in two CDG-Ia patients.
Schollen E; Keldermans L; Foulquier F; Briones P; Chabas A; Sánchez-Valverde F; Adamowicz M; Pronicka E; Wevers R; Matthijs G
Mol Genet Metab; 2007 Apr; 90(4):408-13. PubMed ID: 17307006
[TBL] [Abstract][Full Text] [Related]
4. Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.
Haeuptle MA; Hennet T
Hum Mutat; 2009 Dec; 30(12):1628-41. PubMed ID: 19862844
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik.
Grubenmann CE; Frank CG; Hülsmeier AJ; Schollen E; Matthijs G; Mayatepek E; Berger EG; Aebi M; Hennet T
Hum Mol Genet; 2004 Mar; 13(5):535-42. PubMed ID: 14709599
[TBL] [Abstract][Full Text] [Related]
6. A frequent mild mutation in ALG6 may exacerbate the clinical severity of patients with congenital disorder of glycosylation Ia (CDG-Ia) caused by phosphomannomutase deficiency.
Westphal V; Kjaergaard S; Schollen E; Martens K; Grunewald S; Schwartz M; Matthijs G; Freeze HH
Hum Mol Genet; 2002 Mar; 11(5):599-604. PubMed ID: 11875054
[TBL] [Abstract][Full Text] [Related]
7. Congenital disorder of glycosylation type Ia: searching for the origin of common mutations in PMM2.
Quelhas D; Quental R; Vilarinho L; Amorim A; Azevedo L
Ann Hum Genet; 2007 May; 71(Pt 3):348-53. PubMed ID: 17166182
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of three splicing mutations identified in the PMM2 gene: toward a new therapy for congenital disorder of glycosylation type Ia.
Vega AI; Pérez-Cerdá C; Desviat LR; Matthijs G; Ugarte M; Pérez B
Hum Mutat; 2009 May; 30(5):795-803. PubMed ID: 19235233
[TBL] [Abstract][Full Text] [Related]
9. Mutations in PMM2 that cause congenital disorders of glycosylation, type Ia (CDG-Ia).
Matthijs G; Schollen E; Bjursell C; Erlandson A; Freeze H; Imtiaz F; Kjaergaard S; Martinsson T; Schwartz M; Seta N; Vuillaumier-Barrot S; Westphal V; Winchester B
Hum Mutat; 2000 Nov; 16(5):386-94. PubMed ID: 11058895
[TBL] [Abstract][Full Text] [Related]
10. PMM2 mutation spectrum, including 10 novel mutations, in a large CDG type 1A family material with a focus on Scandinavian families.
Bjursell C; Erlandson A; Nordling M; Nilsson S; Wahlström J; Stibler H; Kristiansson B; Martinsson T
Hum Mutat; 2000 Nov; 16(5):395-400. PubMed ID: 11058896
[TBL] [Abstract][Full Text] [Related]
11. PMM2 intronic branch-site mutations in CDG-Ia.
Vuillaumier-Barrot S; Le Bizec C; De Lonlay P; Madinier-Chappat N; Barnier A; Dupré T; Durand G; Seta N
Mol Genet Metab; 2006 Apr; 87(4):337-40. PubMed ID: 16376131
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of congenital disorders of glycosylation type-I using protein chip technology.
Mills K; Mills P; Jackson M; Worthington V; Beesley C; Mann A; Clayton P; Grunewald S; Keir G; Young L; Langridge J; Mian N; Winchester B
Proteomics; 2006 Apr; 6(7):2295-304. PubMed ID: 16552784
[TBL] [Abstract][Full Text] [Related]
13. PMM2-CDG: phenotype and genotype in four affected family members.
Bortot B; Cosentini D; Faletra F; Biffi S; De Martino E; Carrozzi M; Severini GM
Gene; 2013 Dec; 531(2):506-9. PubMed ID: 23988505
[TBL] [Abstract][Full Text] [Related]
14. The prenatal diagnosis of congenital disorders of glycosylation (CDG).
Matthijs G; Schollen E; Van Schaftingen E
Prenat Diagn; 2004 Feb; 24(2):114-6. PubMed ID: 14974118
[No Abstract] [Full Text] [Related]
15. An activated 5' cryptic splice site in the human ALG3 gene generates a premature termination codon insensitive to nonsense-mediated mRNA decay in a new case of congenital disorder of glycosylation type Id (CDG-Id).
Denecke J; Kranz C; Kemming D; Koch HG; Marquardt T
Hum Mutat; 2004 May; 23(5):477-86. PubMed ID: 15108280
[TBL] [Abstract][Full Text] [Related]
16. A new insight into PMM2 mutations in the French population.
Le Bizec C; Vuillaumier-Barrot S; Barnier A; Dupré T; Durand G; Seta N
Hum Mutat; 2005 May; 25(5):504-5. PubMed ID: 15844218
[TBL] [Abstract][Full Text] [Related]
17. Denaturing high-performance liquid chromatography is a suitable method for PMM2 mutation screening in carbohydrate-deficient glycoprotein syndrome type IA patients.
Erlandson A; Stibler H; Kristiansson B; Wahlström J; Martinsson T
Genet Test; 2000; 4(3):293-7. PubMed ID: 11142762
[TBL] [Abstract][Full Text] [Related]
18. Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic.
Imbach T; Grünewald S; Schenk B; Burda P; Schollen E; Wevers RA; Jaeken J; de Klerk JB; Berger EG; Matthijs G; Aebi M; Hennet T
Hum Genet; 2000 May; 106(5):538-45. PubMed ID: 10914684
[TBL] [Abstract][Full Text] [Related]
19. Identification of phosphorylated oligosaccharides in cells of patients with a congenital disorders of glycosylation (CDG-I).
Vleugels W; Duvet S; Peanne R; Mir AM; Cacan R; Michalski JC; Matthijs G; Foulquier F
Biochimie; 2011 May; 93(5):823-33. PubMed ID: 21315133
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate-deficient transferrin (CDT) as a biochemical tool for the screening of congenital disorders of glycosylation (CDGs).
Biffi S; Tamaro G; Bortot B; Zamberlan S; Severini GM; Carrozzi M
Clin Biochem; 2007 Dec; 40(18):1431-4. PubMed ID: 17920054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
